PMH13 COST-EFFECTIVENESS ANALYSIS OF SINGLE-DOSE EXTENDED RELEASE METHYLPHENIDATE (CONCERTA®) VS. ATOMOXETINE AND SHORT-ACTION METHYLPHENIDATE, FOR THE MANAGEMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY IN MEXICO

May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68766-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)68766-9/fulltext
Section Title :
Section Order : 548
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68766-9&doi=10.1016/S1098-3015(10)68766-9
HEOR Topics :
Tags :
Regions :